Trump takes aim at Texas conservative Chip Roy after he ranted on the House floor

The representative said his fellow lawmakers did not have “a lot of self-respect.” Read More Source link
The representative said his fellow lawmakers did not have “a lot of self-respect.” Read More Source link
Stay informed with free updates Just enter the Power of the EU myFT Digest — delivered straight to your inbox. Imports of Russian liquefied natural gas to the EU have reached a record high this year even as the bloc…
By Humeyra Pamuk and Amina Ismail WASHINGTON/DAMASCUS (Reuters) – US diplomats visiting Damascus held Washington's first official meetings with Syria's new rulers led by Hayat Tahrir al-Sham on Friday and discussed with former al Qaeda the future of Syria's political…
Kenny Polcari, chief market strategist at SlateStone Wealth, notes “nervousness” about Trump's expected tax cuts at Varney & Co. The Fed is the favorite inflation gauge It was lower than expected in November, but remains above the central bank's target…
peterschreiber.media BMO Capital Markets downgraded Exelixis (NASDAQ:Excel) to outperform the market as it sees limited upside for the stock in 2025. The investment firm said it sees a balanced risk/reward for the upcoming reading of zanzalintinib in colorectal cancer, or…
Three Major Banks Sued by CFPB Over Zelle Scams Source link
The government has raised the minimum support price (MSP) for copra to Rs 422, while the new price for the 2025 season has been fixed at Rs 12,100 per quintal. This increase has a financial cost of Rs 855 million.…
© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this website constitutes acceptance of us Terms of Use and Privacy Policy | CA Collection Notice and Privacy Notice | Do Not Sell/Share My Personal InformationFORTUNE is a trademark…
Open Editor's Digest for free Roula Khalaf, Editor of the FT, selects her favorite stories for this weekly newsletter. That the obesity market will be huge is a given, with sales estimated to increase to 150bn by 2030. But it…
In a challenging year for Discovery (NASDAQ: ) Laboratories Inc. , the biotechnology firm's stock (NASDAQ: WINT ) recorded a 52-week low, dipping to $0.32. This recent price level shows a significant decline from previous positions, which includes a dramatic…